ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX)

CUSIP: G6829J107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / ORD SHS
Total 13F shares
231,286,952
Share change
-1,683,163
Total reported value
$4,952,520,758
Put/Call ratio
0%
Price per share
$21.41
Number of holders
105
Value change
-$27,479,187
Number of buys
61
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP G6829J107?
CUSIP G6829J107 identifies OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) as of Q2 2021

As of 30 Jun 2021, ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 231,286,952 shares. The largest 10 holders included Carlyle Group Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., SHAPIRO CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, Boston Partners, LAZARD ASSET MANAGEMENT LLC, and Alyeska Investment Group, L.P.. This page lists 105 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.